Here are four notes:
1. Analysts expect the company’s EPS growth to fall 14.29 percent.
2. During the last trading session, NuVasive stock increased 1.73 percent.
3. The shares have underperformed the S&P 500 by 2.05 percent.
4. NuVasive shares have decreased 13.06 percent since July 2015.
More articles on devices:
Dr. Rick Pospisil to offer carpal tunnel procedures — 5 points
NuVasive establishes new 52-week low: 4 points
Medtronic launches Valleylab FT10 energy platform: 4 highlights
